Both in Biotechnology
Scilex Holding vs Intensity Therapeutics
Over the past year SCLX returned −89.6% and INTS returned −78.2%; their daily moves had a correlation of 0.10.
SCLX −89.6% INTS −78.2%Growth of $1, one year, split-adjusted
| Metric | SCLX | INTS |
|---|---|---|
| Price | $1.85 | $3.38 |
| Market cap | $13.0M | $11.0M |
| Today | −1.07% | −1.46% |
| 1 month | −51.6% | −2.0% |
| 6 months | −82.8% | −35.1% |
| Year to date | −84.8% | −67.0% |
| 1 year | −88.8% | −81.5% |
| Revenue growth (YoY) | −22.8% | — |
| Gross margin | 51.9% | — |
| Net margin | −1501.3% | — |
| P/E (TTM) | — | — |
| Price / sales | 0.4× | — |
| Net cash | -$82.5M | $9.5M |
| Dividend yield | — | — |
| Volatility (60d) | 70.3% | 62.2% |
| Short % of float | 2.4% | 2.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).